C. Amador

发表

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

Chagas disease screening in pregnant Latin American women: Adherence to a systematic screening protocol in a non-endemic country

F. Buñuel, J. Ramos-Rincón, M. Navarro, 2021, PLoS neglected tropical diseases.

Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients

S. Reus, J. Flores, M. Garcia-deltoro, 2017, AIDS.

Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

J. Ena, C. Amador, F. Arjona, 2006, Urology.

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.

J. Ena, C. Amador, F. Pasquau, 2006, Enfermedades infecciosas y microbiologia clinica.

Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients

J. Ena, C. Amador, F. Pasquau, 2003, International journal of STD & AIDS.

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia.

J. Ena, C. Amador, F. Pasquau, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients.

J. Ena, C. Amador, F. Pasquau, 2011, European journal of internal medicine.

Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region

J. Ena, J. Flores, C. Amador, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations

J. Ena, C. Amador, F. Pasquau, 2012, HIV/AIDS.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Eruptive Melanocytic Nevi in Human Immunodeficiency Virus Infection

E. Chiner, I. Betlloch, C. Amador, 1991, International journal of dermatology.

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.

J. Pineda, A. Rivero, J. Portilla, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

D. Podzamczer, J. Mallolas, J. Losa, 2021, Trials.

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.

A. Muriel, S. Moreno, M. Vivancos, 2020, The lancet. HIV.

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study

J. Arribas, J. Blanco, S. Moreno, 2021, HIV medicine.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Pneumonia due to Bordetella bronchiseptica in a patient with AIDS.

E. Chiner, C. Amador, F. Pasquau, 1991, Reviews of infectious diseases.

Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain

F. Gutiérrez, J. Ramos, D. Torrús, 2012, Pathogens and global health.

Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli.

V. Ortiz de la Tabla, J. Ena, C. Amador, 1995, The Journal of urology.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

Erythema Annular Centrifugum in Q Fever

E. Chiner, I. Betlloch, C. Amador, 1991, International journal of dermatology.

Ciprofloxacin as an effective antibacterial agent in serratia endocarditis.

E. Bouza, J. Ena, F. Parras, 1991, The Journal of infection.